FibroBiologics Inc. (NASDAQ: FBLG) Stock Information | RedChip

FibroBiologics Inc. (NASDAQ: FBLG)


$5.32
+0.3150 ( +6.30% ) 132.5K

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Market Data


Open


$5.32

Previous close


$5.00

Volume


132.5K

Market cap


$189.67M

Day range


$4.93 - $5.42

52 week range


$3.90 - $55.00

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 3 Feb 15, 2024
8-k 8K-related 16 Feb 14, 2024
3 Insider transactions 2 Feb 13, 2024
3 Insider transactions 2 Feb 13, 2024
3 Insider transactions 3 Feb 08, 2024
3 Insider transactions 1 Feb 08, 2024
8-k 8K-related 16 Feb 08, 2024
3 Insider transactions 2 Feb 07, 2024
3 Insider transactions 2 Feb 07, 2024
3 Insider transactions 1 Feb 07, 2024

Latest News